Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Sep 24:11:1980.
doi: 10.3389/fimmu.2020.01980. eCollection 2020.

Kinetics of CD4+ T Helper and CD8+ Effector T Cell Responses in Acute Dengue Patients

Affiliations

Kinetics of CD4+ T Helper and CD8+ Effector T Cell Responses in Acute Dengue Patients

Dao Huy Manh et al. Front Immunol. .

Abstract

Background: The protective or pathogenic role of T lymphocytes during the acute phase of dengue virus (DENV) infection has not been fully understood despite its importance in immunity and vaccine development. Objectives: This study aimed to clarify the kinetics of T lymphocyte subsets during the clinical course of acute dengue patients. Study design: In this hospital-based cohort study, 59 eligible Vietnamese dengue patients were recruited and admitted. They were investigated and monitored for T cell subsets and a panel of clinical and laboratory parameters every day until discharged and at post-discharge from the hospital. Results: We described for the first time the kinetics of T cell response during the clinical course of DENV infection. Severe cases showed significantly lower levels of effector CD8+ T cells compared to mild cases at day -1 (p = 0.017) and day 0 (p = 0.033) of defervescence. After defervescence, these cell counts in severe cases increased rapidly to equalize with the levels of mild cases. Our results also showed a decline in total CD4+ T, Th1, Th1/17 cells during febrile phase of dengue patients compared to normal controls or convalescent phase. On the other hand, Th2 cells increased during DENV infection until convalescent phase. Cytokines such as interferon-γ, IL-12p70, IL-5, IL-23, IL-17A showed tendency to decrease on day 0 and 1 compared with convalescence and only IL-5 showed significance indicating the production during acute phase was not systemic. Conclusion: With a rigorous study design, we uncovered the kinetics of T cells in natural DENV infection. Decreased number of effector CD8+ T cells in the early phase of infection and subsequent increment after defervescence day probably associated with the T cell migration in DENV infection.

Keywords: T cell subsets; T helper cells (Th cells); cytokine; cytoxic T cells; dengue.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Flow diagram illustrating patient selection and sample investigation. Fifty-nine symptomatic dengue patients were enrolled. Blood samples were collected each day from the enrolment until discharge. One sample was also obtained 2 weeks after discharge as convalescent sample. T cell subsets were analyzed using these samples (n = 184).
Figure 2
Figure 2
Kinetics of CD8+ and effector CD8+ T cells in mild and severe dengue infection. Number of CD8+ and effector CD8+ T cells from dengue patients was monitored in acute and convalescent phase. Open and closed circles show number of cell count from mild dengue patients and severe dengue patients, respectively. Open triangle shows data from healthy control. Asterisks (*) indicate significant difference (p < 0.05) between mild and severe group on a single day. Hash (#) indicates significant difference (p < 0.05) between healthy control and other groups. M and S indicate mild and severe dengue patients, respectively. Number in parentheses indicates number of samples in each time point. Day 0 denotes defervescence day. Cv and HC indicate convalescent phase and healthy control, respectively.
Figure 3
Figure 3
Kinetics of CD4+, Th1, Th2, Th1/17, and Th17 T cells in mild and severe dengue infection. Number of CD4+, Th1, Th2, Th1/17, and Th17 T cells from dengue patients was monitored in acute and convalescent phase. Open and closed circles show number of cell count from mild dengue patients and severe dengue patients, respectively. Open triangle shows data from healthy control. Asterisks (*) indicates significant difference (p < 0.05) between mild and severe group on a day. Hash (#) indicates significant difference (p < 0.05) between healthy control and other groups. M and S indicate mild and severe dengue patients, respectively. Number in parentheses indicates number of samples in each time point. Day 0 denotes defervescence day. Cv and HC indicate convalescent phase and healthy control, respectively.
Figure 4
Figure 4
Kinetics of plasma cytokine in dengue infection. Cytokines from dengue patients' plasma were monitored in acute and convalescent phase. Open and closed circles show number of cell count from mild dengue patients and severe dengue patients, respectively. Open triangle shows data from healthy control. Asterisks (*) indicates significant difference (p < 0.05) between mild and severe group on a single day. M and S indicate mild and severe dengue patients, respectively. Number in parentheses indicates number of samples in each time point. Day 0 denotes defervescence day. Cv and HC indicate convalescent phase and healthy control, respectively.

Similar articles

Cited by

References

    1. Dengue W. Guidelines for Diagnosis, Treatment. Prevention and Control Geneva: World Health Organization; (2009). - PubMed
    1. Bhatt S, Gething PW, Brady OJ, Messina JP, Farlow AW, Moyes CL, et al. . The global distribution and burden of dengue. Nature. (2013) 496:504–07. 10.1038/nature12060 - DOI - PMC - PubMed
    1. Guzman MG, Gubler DJ, Izquierdo A, Martinez E, Halstead SB. Dengue infection. Nat Rev Dis Primers. (2016) 2:16055 10.1038/nrdp.2016.55 - DOI - PubMed
    1. Sabchareon A, Wallace D, Sirivichayakul C, Limkittikul K, Chanthavanich P, Suvannadabba S, et al. . Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial. Lancet. (2012) 380:1559–67. 10.1016/S0140-6736(12)61428-7 - DOI - PubMed
    1. Guy B, Jackson N. Dengue vaccine: hypotheses to understand CYD-TDV-induced protection. Nat Rev Microbiol. (2016) 14:45–54. 10.1038/nrmicro.2015.2 - DOI - PubMed

Publication types

MeSH terms